tiprankstipranks
Trending News
More News >
Inmune Bio (INMB)
NASDAQ:INMB
US Market

Inmune Bio (INMB) Financial Statements

Compare
874 Followers

Inmune Bio Financial Overview

Inmune Bio's market cap is currently $40.68M. The company's EPS TTM is $-0.24; its P/E ratio is -0.71; Inmune Bio is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K
Gross Profit$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K
Operating Income$ -42.63M$ -29.74M$ -25.95M$ -29.15M$ -12.23M
EBITDA$ -42.08M$ 0.00$ 0.00$ 0.00$ 0.00
Net Income$ -42.08M$ -30.01M$ -27.30M$ -30.34M$ -12.10M
Balance Sheet
Cash & Short-Term Investments$ 20.92M$ 35.85M$ 52.15M$ 74.81M$ 21.97M
Total Assets$ 39.56M$ 57.00M$ 81.80M$ 99.94M$ 40.66M
Total Debt$ 384.00K$ 10.44M$ 15.31M$ 15.23M$ 160.00K
Net Debt$ -20.54M$ -25.41M$ -36.84M$ -59.58M$ -21.81M
Total Liabilities$ 7.46M$ 18.86M$ 21.69M$ 19.72M$ 1.90M
Stockholders' Equity$ 32.10M$ 38.14M$ 60.10M$ 80.22M$ 38.75M
Cash Flow
Free Cash Flow$ -33.36M$ -11.98M$ -22.69M$ -43.50M$ -8.94M
Operating Cash Flow$ -33.36M$ -11.98M$ -22.69M$ -28.50M$ -8.94M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -15.00M$ 0.00
Financing Cash Flow$ 18.21M$ -4.22M$ 729.00K$ 96.36M$ 23.90M
Currency in USD

Inmune Bio Earnings and Revenue History

Inmune Bio Debt to Assets

Inmune Bio Cash Flow

Inmune Bio Forecast EPS vs Actual EPS